Clinical trial
Role of Immunoscore® in Stage II-III Colorectal Cancer
NCT05422547 is registered in ClinicalTrials.gov with D'Or Institute for Research and Education as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Immunoscore® in Stage II-III Colorectal Cancer
- Lead sponsor
- D'Or Institute for Research and Education
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2022
- Completion date
- December 30, 2023
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
colon adenocarcinoma